Chronic Heart Failure Clinical Trial
Official title:
Effect of an Eccentrically Biased Aerobic Exercise Program on Quality of Life and Functional Capacity in People With Chronic Heart Failure: A Randomized Controlled Trial.
Many studies have shown that exercise training is beneficial for patients with chronic heart
failure (CHF). Heart Foundation guidelines strongly recommend regular physical activity and
referral to a specifically designed rehabilitation program for all patients with CHF who are
medically stable. Such programs usually comprise aerobic exercises such as walking, and light
weightlifting with care to avoid heavy straining due to stress that this may place on the
heart.
Eccentric contractions are those in which the muscle lengthens as it contracts. Exercise
involving eccentric contractions is known to increase muscle strength and this type of
exercise also requires less oxygen. This is because it requires less power to resist lowering
a weight than it does to lift a weight. Initial evidence suggests that this form of exercise
has favourable outcomes in the frail elderly and those with chronic disease.
This study aims to determine if eccentric exercise can be applied to patients with heart
failure to increase their physical function while using less energy so that exercise is more
tolerable for patients who complain of significant breathlessness and fatigue. This study
also aims to determine if eccentric exercise is a safe alternative exercise option for
patients at risk of negative events.
The investigators propose to run a randomised controlled trial. Eccentric exercise will be
delivered to a group of heart failure patients referred to the existing heart failure
rehabilitation program at the Northern Hospital. The program will consist of eight weeks of
twice weekly exercise of one hour's duration comprising eccentric exercise combined with
walking and light weight training. This will be compared to a group of patients participating
in the current exercise program consisting of light weightlifting and aerobic exercises for
the same length and duration of exercise and also to a third group of patients who will be
wait listed for 8 weeks. Following the completion of the eight week waiting period, these
patients will be offered the option of joining the standard exercise program.
The investigators expect that the eccentric exercise group will have improved walking
capacity and quality of life compared with the traditional program and the wait-list control
group. It is also possible that there is no difference between the eccentric and traditional
program in terms of functional outcomes but that the participants report that eccentric
exercise is easier.
BACKGROUND A systematic literature review we conducted yielded two trials investigating
eccentric exercise in patients with coronary artery disease and two trials in the chronic
heart failure population. Eccentric exercise was reported to be a safe form of exercise for
coronary patients, causing minimal heart and breathing stress and being perceived as "fairly
light" exertion. Eccentric exercise, when compared with concentric exercise (shortening
contractions) resulted in comparable improvements in muscle strength and walking distance,
often with reduced oxygen usage.
With no increase in negative events with coronary patients, recently eccentric exercise has
been trialed in heart failure patients. One trial looked at six-minute walk test differences
in patients with mild heart failure following a program of eccentric or concentric cycling.
They found that although both groups improved their walking distance, the eccentric exercise
was completed at lower levels of work and stable heart rates. A second trial completed
eccentric exercise by descending stairs, compared with participants who climbed stairs and
measured knee muscle strength. They reported that participants found the stair descending
easy with significant improvements in static strength but not eccentric (lengthening) or
concentric (shortening) force. Both of these studies were limited by a population of a small
number (12-15) of participants primarily males, with poorly defined or mild heart failure.
RESEARCH AIMS Given the limited evidence in coronary patients and more specifically heart
failure patients, this current study aims to fill knowledge gaps by looking at the effects of
eccentric exercise on both males and females, with mild to moderate heart failure, of both
heart failure types- systolic (heart contraction problems) and diastolic (heart relaxation
problems). We aim to include measures of both function and quality of life. We will also
monitor compliance and patient satisfaction with the aim of developing a safe and tolerable
exercise program that is feasible for implementation in heart failure rehabilitation
programs.
METHODS Participants will be recruited through The Northern Hospital heart failure outpatient
medical clinics and also through referral to the current rehabilitation program following
inpatient admission or G.P referral. This study will be a prospective, three-armed,
parallel-design, randomised controlled trial with a 1:1:1 ratio. A separate randomisation
procedure will be prepared for each of the three included New York heart association heart
failure classes so that disease severity will not affect the results.
As well as the primary outcomes of walking capacity and quality of life, secondary outcomes
will include lower limb strength and levels of fatigue. We will also monitor adherence,
attendance, pain, and any adverse events occurring in any session.
Demographic and outcome data will be analysed for between group differences at baseline. To
determine whether group 1 improved more than groups 2 and 3 immediately after the 8-week
program, data will be analysed with analysis of covariance using the baseline measures as
covariates. Categorical outcome variables (death or hospital admission) will be analysed with
relative risk ratios. To avoid bias and to maximise the randomisation process, intention to
treat analysis will be utilised. Participants withdrawing from the project will be followed
up where possible. Where data are missing, the carry forward technique will be used, which
assumes that missing data remain constant. Finally, correlations between the secondary
outcome variables and the primary outcome variables will also be examined to detect where
associations exist as well as associations between outcomes and types of heart failure
(systolic or diastolic). Significance level of P<.05 will be used for hypotheses testing.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03597646 -
The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure
|
N/A | |
Terminated |
NCT04065997 -
Apogee International
|
||
Withdrawn |
NCT03675113 -
Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02916160 -
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
|
Phase 4 | |
Completed |
NCT03126656 -
Effects of Testosterone on Myocardial Repolarization
|
Phase 4 | |
Completed |
NCT02247245 -
The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.
|
N/A | |
Completed |
NCT02268500 -
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
|
Phase 4 | |
Completed |
NCT01919918 -
Muscle Afferent Feedback Effects in Patients With Heart Failure
|
Phase 1 | |
Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
Completed |
NCT00984529 -
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
|
N/A | |
Recruiting |
NCT00863421 -
Sleep Disordered Breathing in Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02840565 -
Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453
|
Phase 1 | |
Completed |
NCT02441218 -
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
|
Phase 3 | |
Completed |
NCT00149409 -
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT05532046 -
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
|
Phase 1 | |
Recruiting |
NCT04984928 -
Readmission Risk of Patients With Heart Failure.
|
||
Completed |
NCT02814097 -
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Active, not recruiting |
NCT05560737 -
ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
|
||
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|